Ankerstar Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$72.1K Sell
275
-33
-11% -$8.46K 0.06% 148
2026
Q2
$77.7K Hold
308
– – 0.07% 140
2026
Q1
$67.1K Sell
308
-23
-7% -$5.1K 0.07% 133
2025
Q4
$75.8K Buy
+331
New +$75.4K 0.08% 116

Other funds holding ABBV

Ankerstar Wealth's ABBV Position: Q3 2026 in Review

Ankerstar Wealth reduced its AbbVie (ABBV) stake by 11% in Q3 2026, selling an estimated $8.46K and leaving 275 shares worth $72.1K. The position accounts for 0.06% of the portfolio, ranked #148.

Ankerstar Wealth first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $77.7K in Q2 2026. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Ankerstar Wealth held 275 shares of AbbVie worth $72.1K as of Q3 2026.
  • Ankerstar Wealth sold 33 AbbVie shares in Q3 2026, an estimated $8.46K.
  • AbbVie made up 0.06% of Ankerstar Wealth's portfolio in Q3 2026, its #148 holding.
  • Ankerstar Wealth first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • Ankerstar Wealth's AbbVie position peaked at $77.7K in Q2 2026.
  • 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.